Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Steroid Refractory Chronic Graft-Versus-Host Disease: Cost-Effectiveness Analysis

18 Mar 2018

Abstract excerpt

Given the increasing incidence of chronic graft-versus-host disease (cGVHD) and its rapidly escalating costs due to many lines of drug treatments, we aimed to perform a meta-analysis to assess the comparative effectiveness of various treatment options. Using these results, we then conducted a cost-effectiveness analysis for the frequently utilized agents in steroid-refractory cGVHD. We searched for studies...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Hematopoietic Stem Cell Transplantation
Share to Mesenchymal stem cell research
Share to Renal Transplantation Outcomes and Treatments

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 29550629
DOI: 10.1016/j.bbmt.2018.03.008

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Steroid Refractory Chronic Graft-Versus-Host Disease: Cost-Effectiveness AnalysisPMID 29550629Read ↗

Emerging novel therapies for steroid-refractory acute graft-versus-host disease: recent advances and future directionsSemantic proximity Read ↗

Biologic therapies for lupus nephritis: a systematic review of efficacy, safety, and cost-effectivenessSemantic proximity Read ↗

Ruxolitinib for Glucocorticoid-Refractory Chronic Graft-versus-Host DiseaseSemantic proximity Read ↗

Severity and organ distribution of graft-versus-host disease with post-transplant cyclophosphamide versus calcineurin inhibitor plus methotrexate/mycophenolate mofetil or sirolimus in allogenic HLA-matched or single-allele mismatched stem cell transplantation.Semantic proximity Read ↗

Chronic graft-versus-host diseaseSemantic proximity Read ↗

Evaluation of Ruxolitinib for Steroid-Refractory Chronic Graft-vs-Host Disease After Allogeneic Hematopoietic Stem Cell TransplantationSemantic proximity Read ↗

Optimal Management of Chronic Lymphocytic Leukemia and Economic Constraints.Semantic proximity Read ↗

Cost-effectiveness Analysis of Rituximab Associated With Fludarabine and Cyclophosphamide (R-FC) for the First-line Treatment of Chronic Lymphocytic Leukemia Under the Brazilian Public Health System (SUS).Semantic proximity Read ↗

Chronic graft-versus-host disease after allogeneic blood stem cell transplantationSemantic proximity Read ↗

Cost-effectiveness of anti-CD20 monoclonal antibody associated with fludarabine and cyclophosphamide (R-FC) for the first-line treatment of chronic lymphocytic leukemia in the Brazilian public health system (SUS)Semantic proximity Read ↗

Success of Immunosuppressive Treatments in Patients with Chronic Graft-versus-Host DiseaseSemantic proximity Read ↗

Cost-Utility and Cost-Effectiveness Analysis of disease-modifying drugs of Relapsing-Remitting Multiple Sclerosis: A Systematic ReviewSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.